Gordon Gibb is a writer, broadcaster and media specialist who has contributed since 2007. His specialty is getting to the heart of an issue quickly, and complex subjects are more easily understood in his hands. His work has appeared in major international magazines and newspapers, and his two books on Nobel Peace Prize winner Lester B. Pearson were published in 2006 and 2015 respectively. A book of essays and newspaper columns entitled ‘Gibberish: Tall Tales and Domestic Disasters from Beyond the Microphone’ was released in 2014. A novel, ‘The Fifth Season,’ is due in 2016. When not writing and producing his daily radio program, Gordon operates a voiceover studio at www.GordonGibb.com and runs an oldies music channel at www.yourKawarthaOLDIES.com.Follow Gordon on
September 19, 2017.
Seattle, WA: One of the world’s leading manufacturers of endoscopes, and a target of a wrongful death trial in an endoscope lawsuit, escaped liability for a patient’s fatal infection but was nonetheless compelled to pay almost $6.6 million to the hospital involved for failing to adequately instruct hospital staff.Read [ Olympus Tagged with Partial Liability in Endoscope Lawsuit ]
September 18, 2017.
Washington, DC: The honeymoon the then-fresh Obama Administration was still largely enjoying in 2010 was nonetheless tainted two years into Barack Obama’s Presidency with revelations that hundreds of Americans supposedly had died due to malfunctioning infusion pumps. The Medtronic SynchroMed insulin pump was among the plethora of infusion pumps that were coming under increased scrutiny by the US Food and Drug Administration (FDA) at the time.Read [ Infusion Pumps, Medtronic SynchroMed among Them, Remain Under Scrutiny ]
September 18, 2017.
Washington, DC: When finasteride (Proscar) was first approved by the US Food and Drug Administration (FDA) as a treatment for benign prostatic hyperplasia (enlarged prostate) in 1992, researchers found higher incidents of sexual dysfunction in study participants taking finasteride when compared against a control group taking a placebo. Two dosages were studied: 5mg, and 1mg. The study, as reported that year in the New England Journal of Medicine, found a higher incidence of impotence, ejaculatory disorders and decreased libido in both treatment groups.Read [ Sexual Dysfunction was Always There, but the Conversation Changed with Propecia ]
September 17, 2017.
Philadelphia, PA: As the manufacturer of Risperdal (risperidone) continues their attempts to have a recent plaintiff verdict overturned, the Pennsylvania state judge assigned to the case explained last month why he denied a request by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. for a new trial in the Risperdal side effects lawsuit.Read [ Risperdal Judge Explains Reasons for Denying Janssen a New Trial ]
September 17, 2017.
New York, NY: It appears as if the recent announcement that Benicar manufacturer Daiichi Sankyo will make available $300 million to settle claims over Benicar side effects will not prove to be a hardship for the Japanese drug maker. The Reuters news agency (08/01/17) reported last month that according to a statement from Daiichi Sankyo, the settlement is expected to be funded by a collective of insurance companies underwriting Daiichi’s liabilities. As such, Daiichi Sankyo said the settlement would not have a material impact on its financial position.Read [ Benicar Settlement Will Have No Material Financial Impact to Daiichi Sankyo ]
September 16, 2017.
Los Angeles, CA: An overtime pay class action launched against an insurance claims administrator achieved preliminary approval earlier this month, when a non-revisionary cash settlement worth $2.5 million was given the nod by Los Angeles Superior Court Judge Carolyn B. Kuhl. The unpaid overtime lawsuit alleged that various policies observed by the defendant forced claims adjusters into situations where they had to work off the clock, foregoing overtime pay, meal and rest breaks.Read [ $2.5 Million California Overtime Settlement Granted Preliminary Approval ]
September 15, 2017.
Los Angeles, CA: A defendant continuing to fight a damages award totaling $8.7 million in a California wrongful termination and harassment case appeared before a California appellate panel last month asking the Court to discard the award based on their claim that the trial judge prejudicially excluded evidence demonstrating legitimate, nondiscriminatory grounds for terminating the plaintiff from his job.Read [ Rite Aid Appeals $8.7 Million Award in Discrimination and Harassment Lawsuit ]
September 14, 2017.
Philadelphia, PA: A surgical mesh lawsuit plaintiff whose case fell to a defense verdict at trial, may nonetheless come away with something after the trial judge granted the plaintiff’s petition for damages. The manufacturer of the pelvic mesh involved, Ethicon Inc. (Ethicon), has appealed the judge’s ruling that the matter can progress to a damage hearing. In so doing, Kimberly Adkins’ case has been revived, at least for now.Read [ Surgical Mesh Manufacturer to Appeal Revival of Mesh Lawsuit ]
September 13, 2017.
Atlanta, GA: A Georgia mother who accused her nurse midwife of negligence which allegedly led to injuries suffered by the plaintiff’s child will not have her Georgia medical malpractice lawsuit revived unless she is prepared to take the matter to a higher court.Read [ Georgia Medical Malpractice Lawsuit Lost on Appeal ]
September 13, 2017.
Dublin, IRELAND: A decision last month by a Dublin-based manufacturer of transvaginal mesh to wind up all known US claims associated with transvaginal mesh complications flew under the radar, but is nonetheless worth three-quarters of a billion dollars.Read [ Irish TVM Manufacturer Announces Settlement Pool worth $775 Million ]